Early detection of chronic kidney disease in a diabetic population. A massive screening program in primary healthcare in a middle-income country

Author:

Miguel Mejía-Arias1,Lastiri-Quirós H. Santiago2,Obrador Gregorio T.3,Palacio-Mejía Lina Sofía4ORCID,Hernández-Avila Juan Eugenio4,Amezcua Mario Márquez5,Tamayo-Ortiz Marcela6,Alvarez-Aceves Mariana4,Guzmán-Sandoval Leslie4,Hernández-Avila Mauricio6,Tamayo-Orozco Juan Alfredo7

Affiliation:

1. Fundación Franco-Mexicana para la medicina IAP

2. GlobalMed

3. Universidad Panamericana - Campus México: Universidad Panamericana

4. National Institute of Public Health: Instituto Nacional de Salud Publica

5. Jalisco State Government: Gobierno del Estado de Jalisco

6. IMSS: Instituto Mexicano del Seguro Social

7. Accesalud

Abstract

Abstract Background Early detection of chronic kidney disease (CKD) allows health professionals and patients to take actions to slow physical impairment and prevent or delay dialysis or transplantation and their catastrophic costs. In this study, we aimed to describe a CKD massive screening program in patients with diabetes to explore the feasibility of massive detection of CKD in high-risk patients. Methods We performed a descriptive, cross-sectional study with people living with diabetes, at the primary healthcare units of the Ministry of Health in Jalisco, Mexico. They underwent a screening including a health history questionnaire, somatometry, urinary albumin, serum creatinine, and estimated glomerular filtration rate (eGFR) in accordance with the Kidney Early Evaluation Program (KEEP). We described demographic and clinical characteristics of the population by sex and calculated the prevalence of each CKD stage. Results Of 7,693 recruited patients, 44% were identified with CKD; 35% were in early stages (1 or 2), and 9% in stages 3 to 5. Less than 1% of total patients had previous CKD diagnosis. Among other clinical characteristics, we found that 83% of all patients were overweight or obese and 79% had blood pressure values over 130/80 mmHg. Conclusions This study shows the technical feasibility and usefulness of massive CKD screening campaigns in high-risk people at primary healthcare services. Patients with renal function impairment, who require treatment for preventing disease progression, were identified. It is essential to formulate public policies aimed at protocolization of timely medical interventions to address the incidence and prevalence of CKD.

Publisher

Research Square Platform LLC

Reference17 articles.

1. PAHO (2021) La carga de diabetes mellitus en la región de las Américas 2000–2019. https://www.paho.org/es/enlace/carga-diabetes-mellitus. Accessed 29 Aug 2022

2. Shamah-Levy T, Romero-Martínez M, Barrientos-Gutiérrez T et al (2021) Encuesta Nacional de Salud y Nutrición 2020 sobre Covid-19. Resultados nacionales. Cuernavaca, México

3. Instituto nacional de estadística geografía e informática (2021) Características de las defunciones registradas en México durante 2020, preliminar. México City

4. KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease;Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group;Kidney Int,2020

5. Abbasi M, Chertow GM, Hall YN(2010) End-stage renal disease. BMJ Clin Evid 2002

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3